The Center for Strategic and International Studies (CSIS) Task Force on HIV/AIDS, co-chaired by Senators Bill Frist (R-TN) and Russell Feingold (D-WI), outlines strategic choices that the United States faces in fighting the global HIV/AIDS pandemic. The Task Force seeks to build bipartisan consensus on critical U.S. policy initiatives promoting…
HIV/AIDSSee more about HIV/AIDS
- view as grid
- view as list
Donor governments, including the United States and European nations, provide the bulk of international funding for health in low- and middle- income countries each year. Despite significant increases in such funding, however, it still falls short of need as estimated by the World Health Organization’s Commission on Macroeconomics and Health.…
Enhancing the Rapid Response Capacity of the U.S. Global AIDS Coordinator: Lessons from Other U.S. Emergency Responses
This report from the The Center for Strategic and International Studies (CSIS) Task Force on HIV/AIDS, in collaboration with the Kaiser Family Foundation, reviews the emergency response capacities of a number of US government agencies and makes suggestions for enhancing the rapid-response capacity of the Office of the Global AIDS…
The Global HIV Prevention Working Group is a panel of nearly 50 leading public health experts, clinicians, biomedical, and behavioral researchers, and people affected by HIV/AIDS, convened by the Bill & Melinda Gates Foundation and the Kaiser Family Foundation. Executive Summary (.pdf) Report (.pdf) Press Release (.pdf)
Since the mid-1990s the Kaiser Family Foundation has partnered with U.S.-based media companies on comprehensive HIV/AIDS campaigns. This paper, published in Health Affairs, Vol. 24, Issue 3, May/June 2005, outlines the unique public education model that it is using, and how Kaiser is expanding this work globally by working with some…
This report provides the first comprehensive look at the U.S. government agencies and programs involved in the nation’s global health response, including their funding and their approaches. The report also provides overviews of the large-scale global health initiatives of the U.S. government, information on which countries receive support from the U.S., and a review of the key laws governing U.S. global health policy and relevant Congressional committees.
This session will explore how policy makers and programme managers can work with the current state of knowledge and unanswered questions about what works in HIV prevention to develop strategic, combination prevention responses.
AIDS 2012: Comprehensive HIV Prevention for People Who Use Drugs: Ways Forward for Inclusion of Needle and Syringe Exchange Programmes
This session will address the potential impacts of restrictions on NSEPs, and propose ways forward for public health actors, community stakeholders, and drug users themselves to maintain and expand comprehensive services, including needle and syringe exchanges, despite the limitations in funding, restrictive political environments, and other barriers to the implementation of this preventive intervention.
This session will bring together some of these global leaders to discuss how, in their experience, public-private partnerships are an innovative way to bring together diverse organizations and target the same goal of efficient local programmes that, at the same time, translate into powerful advocacy tools at the global level.
This session will present examples of in-country ownership for developing strategies and solutions for achieving national HIV goals, drawing on the perspectives of government and business sectors.